← Eichor
Study identifier: NCT06862180 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effect of Meal Replacement Therapy on Glucose Control and Metabolic Parameters in Patients With Uncontrolled Diabetes

Condition: Diabetes Mellitus, Type 2  ·  Sponsor: Hospital Universiti Sains Malaysia

PhaseNA
Planned participants108
Who can joinAll sexes, 30 Years to 65 Years
Healthy volunteersNo

About this study

To evaluate the effect of meal replacement therapy on glucose control and other metabolic parameters in patients with uncontrolled type 2 diabetes. Methodology: This is an open-label, prospective, randomized control trial study. Study duration. August 2023 - March 2026. Study location. This study will be conducted at the Klinik Rawatan Keluarga and diabetes clinic Hospital Universiti Sains Malaysia. Source Reference : People with type 2 diabetes mellitus attending the Hospital Universiti Sains Malaysia. Study source population : People with type 2 diabetes mellitus attended Klinik Rawatan Keluarga and diabetes clinic Hospital Universiti Sains Malaysia during the study period.

This description comes directly from the study's public registry record.

Talk to the study team

kanmani kumaran, MD  ·  +60135125136  ·  kanmanikumaran@yahoo.com

Nani Draman, Masters  ·  +601115184421  ·  drnani@usm.my

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Universiti Sains MalaysiaKubang Kerian, Kelantan, MalaysiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06862180